Arthritis Research UK: Translational medical technologies development fund
Date: October 16, 2017
Arthritis Research UK is seeking to support innovation and translation in medical technologies to address MSK conditions, with particular emphasis on developments with clearly defined commercialisation routes. This is the third translational medical technologies call in partnership with the Medical Technologies Innovation Knowledge Centre (IKC).
Maximum duration: up to 2 years
Maximum costs: £100,000
Deadline: expression of interests 11 December 2017
Contact: Paul Thornhill at email@example.com or Graeme Howling at G.Howling@leeds.ac.uk
What does the translational medical technologies development fund provide?
Funding is intended to develop or evaluate innovative technologies that help support individuals suffering with musculoskeletal conditions; in particular projects that develop the following:
- Medical devices
- implantable therapeutic delivery
Who can apply for funding?
Any academic, clinician and allied health care professional at a UK institution.
Collaborations with industry are strongly encouraged.
What can you apply for?
Maximum support that can be requested is £100,000.
Requested salary costs should be based on a recognised pay model or the host institution’s local salary scale, including London weighting if appropriate. We must be advised of the pay model used and, where a local pay model is to be applied, a copy of the appropriate scale must be sent with the application. Annual increments must be included which should be based on the host institution’s own salary scale, including London weighting if appropriate.
Those interested in learning more about the call are encouraged to read the Medical Technologies Proof of Concept Award call document.
How to apply
Read about our partnership with Arthritis Research UK:
Dual matrix scaffold provides better support case study (opens in a new tab)
Translation through collaboration with Arthritis Research UK blog (opens in a new tab)Back to All Events